in collaboration with Cedars-Sinai Accelerator+ x Erasmus MC
Rotterdam Square is proud to present the NL USA Health Accelerator
We are pleased to announce the first joint accelerator between Cedars-Sinai Accelerator+ and Erasmus MC. A six-week program run by Rotterdam Square that culminates in a tailor-made, 5-day program designed exclusively for NL HealthTech, MedTech, and Biotech startups who want to scale in the USA.
This unique initiative is a collaboration between Cedars-Sinai Accelerator+, Erasmus MC, NBSO Los Angeles, and ScaleNL. The program starts October 5, in Rotterdam and culminates five weeks later in sunny Los Angeles, the week of November 9, right before HLTH USA.
About
Our Mission: To accelerate innovation in healthcare and improve patient care
About the program
The NL USA Health Accelerator follows a mentorship-driven approach, aimed at assisting early-stage companies at growing their Dutch-based business and entering the US market to expand their business. You will get a unique opportunity to meet clinicians from Erasmus MC and from the Cedars-Sinai Accelerator+ network to accelerate the development, growth, and traction of your product and company.
Through close collaboration with clinicians, executives, researchers, and other seasoned professionals, you will gain profound insights into the intricate demands of both patients and providers within the Dutch and US contexts. Aside from mentorship, participating companies will join specialized workshops and lectures delivered by industry experts on topics like reimbursements, the US payment systems, legal considerations: EMA Approvals, FDA Approvals & securing your IP.
Tap into a world-class pool of experts in the Netherlands and US.
Don’t miss this opportunity to jumpstart your journey into the US Healthcare space!
Why join the program?
Get a unique opportunity to have coaching and mentorship from cutting-edge researchers and clinicians at both Erasmus MC and Cedars-Sinai. Erasmus MC Rotterdam is known for pioneering clinical medicine, complex patient care, and world-class medical research.
Cedars-Sinai is a front-runner in the US healthcare landscape and has ample experience working with and investing in startups. Focus areas of this program will include:
● Gaining insight into the Dutch Healthcare & US healthcare markets
● Increasing company visibility and expanding your network of mentors, investors, and potential customers
● Translating your value proposition and ROI definition to the US context
● Validating product-market fit with stakeholders from the health system
● Connecting with other healthcare entrepreneurs to share best practices
Together, we power the next generation of NL Health, MedTech, and Biotech
What to expect from the program?
- Pre-arranged mentor meetings
- Insight into the regulatory environment
- Insights into the payor landscape
- Insights into raising money in the US marketplace
- Strategic guidance on how to scale innovation at Cedars-Sinai
- Insights into Cedars-Sinai’s electronic medical record system (Epic) and potential for integration
- Insights into various operational and clinical departments at Cedars-Sinai
- Build connections with Erasmus MC clinicians and researchers driving the frontier of their fields.
- Learn how a tertiary hospital operates and how to work effectively with it, from the Erasmus MC perspective.
General networking with a cross section of subject matter experts and key opinion leaders
The participating founder or CEO needs to be available to participate in person for the launch week (October 5th), Pre-trip week (November 2) in Rotterdam and the US program in Los Angeles (November 9-13). Participation for the entire week is required. During the week in LA, we ask that you keep your schedule open during US business hours and be on time for all mentor sessions.
Your team members are welcome to join the program virtually, alongside the founder who will be participating in person in Los Angeles.
Timeline
From Rotterdam to LA in just 6 weeks!
FAQ
Who is the NL USA Health Accelerator for?
The NL USA Health Accelerator is designed for early-stage HealthTech, MedTech, and Biotech startups that:
- Are based in the Netherlands
- Have at least two full-time employees associated with the company
- Have a clear ambition to scale to the U.S. market
- Have moved beyond concept development and possess a functional prototype, MVP, or validated proof-of-concept
The program unfortunately won’t be a great fit for:
- B2C companies
- Companies beyond Series A
What does the NL USA
Health Accelerator cost?
Participating companies can join the NL USA Health Accelerator for a fee of €2,500, gaining access to a unique opportunity to accelerate their growth and connect with key stakeholders in both the Netherlands and the U.S. health innovation ecosystems.
Travel-related expenses for the Los Angeles program are not included. Companies that choose to extend their stay to attend HLTH USA are welcome to do so at their own expense.
For questions
+31 6 48 495 222Apply now
Ready to learn more about the US healthcare market from world-class experts?
